Literature DB >> 12958217

Proteolysis of normal and mutated steroidogenic acute regulatory proteins in the mitochondria: the fate of unwanted proteins.

Zvi Granot1, Ruth Geiss-Friedlander, Naomi Melamed-Book, Sarah Eimerl, Rina Timberg, Aryeh M Weiss, Karen H Hales, Dale B Hales, Douglas M Stocco, Joseph Orly.   

Abstract

Steroidogenic acute regulatory protein (StAR) is a nuclear encoded mitochondrial protein that enhances steroid synthesis by facilitating the transfer of cholesterol to the inner membranes of mitochondria in hormonally regulated steroidogenic cells. It is currently assumed that StAR activity commences before or during StAR import into the mitochondrial matrix. The present study was designed to demonstrate that, once imported and becoming physiologically irrelevant, exhaustive accumulation of StAR must be limited by a rapid degradation of the protein to prevent potential damage to the organelles. The use of uncouplers and manipulation of the interior mitochondrial pH in hormone-induced ovarian granulosa cells and StAR-expressing COS cells suggests that StAR degradation is biphasic and involves two classes of proteases. During phase I, which normally lasts for the first approximately 2 h following import, StAR is rapidly degraded by a protease, or proteases, that can be arrested by a nonclassical action of proteasome inhibitors such as MG132. StAR molecules that evade phase I are subjected to a second class of protease(s), which is slower and MG132 resistant. A third proteolytic entity was revealed in studies with C-28 StAR, a loss-of-function mutant of StAR. Upon initiation of its import, C-28 StAR dissipates the inner membrane potential and causes swelling of the mitochondria. Degradation of C-28 StAR, probably by an intermembrane space protease, is extremely rapid and MG132 insensitive. Collectively, this study defines StAR as the first naturally occurring mitochondrial protein that can serve as a substrate to probe multiple proteolytic activities in mammalian mitochondria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958217     DOI: 10.1210/me.2003-0074

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  23 in total

1.  Identification of the proteasome inhibitor MG262 as a potent ATP-dependent inhibitor of the Salmonella enterica serovar Typhimurium Lon protease.

Authors:  Hilary Frase; Jason Hudak; Irene Lee
Journal:  Biochemistry       Date:  2006-07-11       Impact factor: 3.162

2.  Leveraging Peptide Substrate Libraries to Design Inhibitors of Bacterial Lon Protease.

Authors:  Brett M Babin; Paulina Kasperkiewicz; Tomasz Janiszewski; Euna Yoo; Marcin Dra G; Matthew Bogyo
Journal:  ACS Chem Biol       Date:  2019-09-10       Impact factor: 5.100

3.  Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis.

Authors:  Andrew Midzak; Nagaraju Akula; Laurent Lecanu; Vassilios Papadopoulos
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

4.  Infarct-induced steroidogenic acute regulatory protein: a survival role in cardiac fibroblasts.

Authors:  Eli Anuka; Natalie Yivgi-Ohana; Sarah Eimerl; Benjamin Garfinkel; Naomi Melamed-Book; Elena Chepurkol; Dan Aravot; Tova Zinman; Asher Shainberg; Edith Hochhauser; Joseph Orly
Journal:  Mol Endocrinol       Date:  2013-07-05

5.  Neuropeptide Y acts within the rat testis to inhibit testosterone secretion.

Authors:  Camryn D Allen; Beatrice Waser; Meike Körner; Jean Claude Reubi; Soon Lee; Catherine Rivier
Journal:  Neuropeptides       Date:  2010-11-26       Impact factor: 3.286

Review 6.  Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions.

Authors:  Adina Turcu; Joshua M Smith; Richard Auchus; William E Rainey
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

7.  Bacterial endotoxin lipopolysaccharide and reactive oxygen species inhibit Leydig cell steroidogenesis via perturbation of mitochondria.

Authors:  John A Allen; Thorsten Diemer; Paul Janus; Karen Held Hales; Dale B Hales
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

8.  StAR enhances transcription of genes encoding the mitochondrial proteases involved in its own degradation.

Authors:  Assaf Bahat; Shira Perlberg; Naomi Melamed-Book; Ines Lauria; Thomas Langer; Joseph Orly
Journal:  Mol Endocrinol       Date:  2013-01-01

Review 9.  Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer.

Authors:  Marcello Pinti; Lara Gibellini; Yongzhang Liu; Shan Xu; Bin Lu; Andrea Cossarizza
Journal:  Cell Mol Life Sci       Date:  2015-09-12       Impact factor: 9.261

Review 10.  Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives.

Authors:  Pulak R Manna; Matthew T Dyson; Douglas M Stocco
Journal:  Mol Hum Reprod       Date:  2009-03-25       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.